FDA Inspection 951256 — Biogen U.S. Corporation

Biogen U.S. Corporation — FEI 3010164829

The FDA completed an inspection of Biogen U.S. Corporation on Dec 10, 2015 in Morrisville, NC. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 5 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Dec 10, 2015
Fiscal Year
2016
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Morrisville, NC (United States)

Citations

IDCFRDescription
121321 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
135821 CFR 211.100(b)SOPs not followed / documented
143321 CFR 211.42(c)(10)(iii)Air Supply
433621 CFR 211.150Written distribution procedure
434021 CFR 211.142Written warehousing procedures established/followed